R-GNOSIS (282512)

  https://cordis.europa.eu/project/id/282512

  FP7 (2007-2013)

  Resistance in Gram-Negative Organisms: Studying Intervention Strategies

  Management of Gram negative multi-drug resistant infections (HEALTH.2011.2.3.1-3)

  public health  ·  surgical specialties  ·  antibiotics  ·  multidrug resistance  ·  antibiotic resistance

  2011-10-01 Start Date (YY-MM-DD)

  2017-03-31 End Date (YY-MM-DD)

  € 15,654,161 Total Cost

  Description

Antibiotics are a mainstay of public health, but their use has increased exponentially leading to the emergence of antibiotic resistance. The R-GNOSIS (Resistance in Gram-Negative Organisms: Studying Intervention Strategies) project combines 5 international clinical studies, all supported by highly innovative microbiology, mathematical modelling and data-management, to determine - in the most relevant patient populations - the efficacy and effectiveness of cutting-edge interventions to reduce carriage, infection and spread of Multi-Drug Resistant Gram-negative Bacteria (MDR-GNB). All work-packages will progress science beyond the state-of-the-art in generating new and translational clinically relevant knowledge, through hypothesis-driven studies focussed on patient-centred outcomes. The 5 clinical studies will investigate the following interventions: •A Point-Of-Care-Testing guided management strategy to improve appropriate antibiotic prescription for uncomplicated UTI in primary care. •Gut decolonization in outpatients with intestinal carriage of MDR-GNB. •A “test and prescribe” strategy, based on rapid diagnostic testing of faeces for MDR-GNB to optimize antibiotic prophylaxis in colo-rectal surgery. •Contact Isolation of patients with ESBL-producing Enterobacteriaceae in general hospital wards. •Three Decolonization strategies in ICUs. Seven laboratories across Europe will perform microbiological analyses, as well as unique quantitative experiments. All information will be integrated by 3 groups of mathematical modellers into highly innovative models to better understand and predict future trends and effects of interventions. The studies and analyses proposed in R-GNOSIS will generate a step-change in identifying evidence-based preventive measures and clinical guidance for primary care and hospital-based physicians and health-care authorities, to combat the spread and impact of infections caused by MDR-GNB in Europe.

  Complicit Organisations

2 Israeli organisations participate in R-GNOSIS.